Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - OPERATING EXPENSES
Operating Expenses FATE - Fate Therapeutics, Inc.
254 M
LAST VALUE
-3.51%
2 YEAR CAGR
28.74%
5 YEAR CAGR
29.85%
10 YEAR CAGR